PDS Biotechnology Corporation — Quarterly Cash Flow (NASDAQ:PDSB) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics Dividends

Quarterly Annual

Total assets 52.45 M45.36 M47.03 M40.48 M34.71 M Total liabilities 30.45 M26.35 M24.67 M24.52 M25.25 M Total equity 22 M19 M22.36 M15.96 M9.45 M Total liabilities & shareholders' equities 52.45 M45.36 M47.03 M40.48 M34.71 M Total debt ————— Net debt —————

뉴스

PDS 바이오텍, 3상 시험 변경… 신속 승인 경로 추가

PDS Biotech amends Phase 3 trial to add accelerated approval path

PDS Biotech reports 9.6-month progression-free survival in prostate cancer study

PDS 바이오, 암 면역치료제 PDS0101 특허 확보

PDS Biotech secures patent for cancer immunotherapy PDS0101

PDS Biotech, FDA 회의 후 주가 급등: 승인 가속화 기대

PDS Biotech stock soars after FDA meeting provides accelerated approval path

PDS 바이오텍, 3상 암 임상시험 수정안 제출

PDS Biotech submits amended protocol for phase 3 cancer trial

PDS Biotech secures new patent for cancer immunotherapy in Japan

PDS Biotechnology (PDSB) Upgraded to Buy: Here's Why

PDS Biotech, FDA와 신속 승인 논의